Building on its foundation in insect, mammalian, and bacterial expression, OET has expanded its offering to include high-precision protein sequencing services powered by Quantum-Si’s Platinum® platform, helping bring next-generation protein analysis to a broader range of researchers and drug developers.
Releases List Price of Proteus™ Platform Reiterates Proteus Development Program On Track for Year End 2026 Launch BRANFORD, Conn.–(BUSINESS WIRE)–Mar. 3, 2026– Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), a proteomics technology company redefining protein analysis through single-molecule detection, today announced financial results for the fourth quarter and full year ended December 31, […]
BRANFORD, Conn.–(BUSINESS WIRE)–Jan. 28, 2025– Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, and IDEX Health & Science, LLC., today announced they will partner on the development and manufacturing of the optics module for Quantum-Si’s novel proteomics platform, Proteus™. IDEX Health & Science, LLC is the global leader in life […]
Platinum Pro, the next-gen protein sequencing (NGPS) platform from Quantum-Si, makes proteomic discoveries convenient and accessible while delivering deeper insights. Platinum Pro offers a benchtop solution with a simple workflow, small footprint, and single-molecule resolution to bring the power of protein sequencing to every lab, everywhere.
Provides Update on the Company’s Innovation Roadmap & New Development Partnerships Highlights new Distribution Agreement with Avantor in the U.S. and Canada BRANFORD, Conn.–(BUSINESS WIRE)–Nov. 21, 2024– Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced the highlights of an Investor & Analyst event that was hosted in New […]
Sales Pipeline is Accelerating and New Kits Remain on Track for Q4 Launch BRANFORD, Conn.–(BUSINESS WIRE)–Nov. 12, 2024– Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced financial results for the third quarter ended September 30, 2024. Press Release Highlights Reported revenue of $787,000 for the third quarter of […]
https://themedicinemaker.com/issues/2024/articles/oct/the-multifaceted-future-of-pharma/
https://www.technologynetworks.com/tn/blog/the-next-big-thing-in-genomics-proteomics-391565
Genetic Engineering & Biotechnology News
https://www.genomeweb.com/proteomics-protein-research/quantum-si-protein-sequencing-tech-draws-interest-prominent-mass-spec